William J. Graber, MD
Department of Urology, Division of Surgery
About Dr. William J. Graber
Present Title & Affiliation
Primary Appointment
Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1991 | Tulane University School of Medicine, New Orleans, Louisiana, US, MD |
| 1987 | University of Texas, Austin, Texas, US, Biochemistry, BA |
Postgraduate Training
| 1996-1997 | Chief Residency, Urology, University of Texas Health Science Center, Houston, Texas |
| 1992-1996 | Clinical Residency, Urology, University of Texas Health Science Center, Houston, Texas |
| 1991-1992 | General Surgery Internship, General Surgery, University of Texas Health Science Center, Houston, Texas |
Licenses & Certifications
| 2001 | Montana State Board of Medical Examiners |
| 2000 | Diplomat, American Board of Urology |
| 1998 | Idaho State Board of Medical Examiners |
| 1997 | Texas State Board of Medical Examiners |
| 1991 | Louisiana State Board of Medical Examiners |
Experience & Service
Other Professional Positions
Assistant Medical Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Member, South Central Section, American Urological Association, Houston, TX, 2011 - Present
Member, Texas Medical Association, Houston, TX, 2010 - Present
Member, American Urological Association, Houston, TX, 1992 - Present
Honors & Awards
| 1991 - 1993 | General Surgery Outstanding Resident Award, University of Texas Health Science Center at Houston, Department of Surgery |
Selected Presentations & Talks
Local Presentations
- 2017. Benign Urologic Issues in the Cancer Patient. Conference. MDACC. Houston, TX, US.
Selected Publications
Peer-Reviewed Articles
- Deboever, N, Eisenberg, M, Niu, J, Graber, WJ, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Swisher, SG, Vaporciyan, AA, Walsh, GL, Giordano, SH, Rajaram, R, Rice, DC. Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB. Journal of surgical oncology 131(5):793-803, 2025. e-Pub 2025. PMID: 39635913.
- Singh J, Wang L, Smith TG, Graber W, Matin S, Pisters L, Lenaine Westney O. Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center. Urology 183:215-220, 2024. e-Pub 2024. PMID: 37802194.
- Geskin AA, Westney OL, Graber WJ, Smith Iii TG, Chapin BF, Gregg JR. Complications Of Peri-Operative Ureteral Catheter Placement: Experience at A Major Cancer Center. Urology 164:88-93, 2022. e-Pub 2022. PMID: 34280440.
- Benson CR, Ajay D, Barrett-Harlow BL, Cunningham KG, Bootwala Y, Pendleton C, Li H, Ayoub HI, Graber WJ, Westney OL. Ureteroenteric anastomosis in orthotopic neobladder creation: do urinary tract infections impact stricture rate?. World J Urol 39(4):1171-1176, 2021. e-Pub 2021. PMID: 32468109.
- Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int 121(4):540-548, 2018. e-Pub 2018. PMID: 28941030.
- Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy 17(2):265-276, 2018. e-Pub 2018. PMID: 29269207.
- Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2018. PMID: 29229325.
Patient Reviews
CV information above last modified March 25, 2026